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Apoptosis: A mechanism for regulation of the cell complement
of inflamed glomeruli
JOHN SAVILL
Renal Unit, Department of Medicine, Royal Postgraduate Medical School, Hammersmith Hospital, London, England, United Kingdom
"Apoptosis" or "programmed cell death" is a regulated
mechanism for deletion of "unwanted" cells. Recent research
indicates a crucial role for apoptosis in a number of fields of
biological science, including immunological tolerance, embry-
ology and neoplasia. This article emphasizes the potential
importance of this process in determining the glomerular re-
sponse to inflammation. Thus, there is evidence that apoptosis
in infiltrating leucocytes is a mechanism for clearance of such
cells which is likely to promote resolution rather than persis-
tence of glomerulonephritis. Furthermore, programmed death
of intrinsic cells which have undergone unwanted proliferation
may enable a pathologically hypercellular glomerulus to return
to normal. However, before discussing these potential roles of
apoptosis, current concepts of this process are summarized.
Cell death: Necrosis versus apoptosis
Death of a nucleated eukaryotic cell can be classified into two
distinct types [1, 2].
Necrosis.Necrosis occurs after gross insults to the cell, such
as hypoxia, high temperature, and exposure to high concentra-
tions of toxins, all of which inhibit membrane cation pumps.
This type of cell death can also follow "attack" by complement
components or lytic viruses, which directly damage the plasma
membrane. In either circumstance, the cell becomes abnor-
mally permeable to ions and water, undergoes reversible and
then irreversible swelling and blebbing, and finally disinte-
grates. The structure of organdies such as mitochondria is
disrupted, protein synthesis declines and there is flocculation of
nuclear chromatin, which nevertheless remains in an approxi-
mately normal pattern. In an intact organism, necrosis is
precipitated by stimuli which affect contiguous tracts of cells;
consequently there is usually sufficient tissue damage to incite
an acute inflammatory response.
Apoptosis.By contrast, apoptosis is a tightly controlled mode
of cell death which is "programmed" in two ways [1, 21. First,
although there may be variations in detail, all cells undergoing
apoptosis follow a basic program of biochemical and morpho-
logical events. Second, in many circumstances there appears to
be an organized program of deletion of cells by apoptosis within
an individual. This concept is best illustrated by developmental
cell death in the embryo; in an exquisitely regulated manner,
apoptosis leads to elimination of interdigital cells during remod-
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elling of the solid limb paddle to form fingers or toes. Apoptosis
programmed in this sense also occurs in endocrine-dependent
tissue atrophy, metamorphosis, tumor regression and in the
control of normal tissue turnover in many organs. Unlike
necrosis, apoptosis frequently occurs in cells apparently dis-
tributed at random deep within a tissue. A further critical
difference is that programmed cell death does not incite inflam-
mation—indeed it is often thought of as being physiological
rather than pathological. This connotation is implicit in the
meaning of "apoptosis", which in ancient Greek is the "falling
off" as of leaves from an autumnal tree—a regulated, physio-
logical event subject to control by external stimuli.
Apoptosis was first defined on the basis of a highly charac-
teristic series of morphological changes [1, 2]. These begin with
rounding up and shrinking of the cell associated with cytoplas-
mic condensation and loss of microvilli from the surface. The
endoplasmic reticulum dilates but mitochondria and other or-
ganelles remain intact. There is rapid condensation of chroma-
tin into dense crescent-shaped aggregates at the periphery of
the nucleus, and complex nuclei such as that of the neutrophil
may coalesce into a single body (Fig, 1A, B). Critically, the cell
membrane remains intact for several hours (excluding vital dyes
such as Trypan blue), and in vivo the apoptotic cell is swiftly
recognized and ingested while still intact by local phagocytes,
before final destruction by the lysosomal enzymes of the
phagocyte. In some cells undergoing programmed death there is
nuclear segmentation and budding off from the cell of mem-
brane-bound "apoptotic bodies" containing cytoplasmic organ-
elles and nuclear fragments. Phagocytes also recognize and
ingest these bodies. Macrophages are the "professional phago-
cytes" removing apoptotic cells/bodies, but other cell types
(including neighboring cells in epithelia or tumors) can partici-
pate. In vitro, apoptotic cells deprived of contact with phago-
cytes eventually undergo swelling and disintegrate.
In 1980 Wyllie associated the morphological changes of
apoptosis with internucleosomal cleavage of chromatin into low
molecular weight double-stranded fragments which are integer
multiples of 180 to 200 base pairs of DNA [3]. These form a
highly characteristic "ladder" on gel electrophoresis of ex-
tracted DNA, and this is now regarded as the biochemical
hallmark of the process (Fig. 1C). This pattern is not seen in
necrotic cell death, where prior to disintegration there may be
digestion of chromatin into a continuous spectrum of sizes,
indicating destruction of histones by proteases and exposure of
the entire length of DNA to endonucleases. The cleavage
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pattern of apoptosis can be mimicked by micrococcal nuclease particularly vulnerable in trascriptionally active regions [4].
in the presence of protease inhibitors, and reflects access of Consequently, it is widely assumed that the key event in
enzyme to linker DNA between nucleosomes, which may be apoptosis is activation of an endogenous endonuclease. Present
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Fig. 1. Features of neutrophil apoptosis. A. Morphology. Photomicrograph of cytospin preparation of human neutrophils isolated from
inflammatory joint fluid and "aged" in culture for 8h. Many cells (examples arrowed) show condensation of cytoplasm and nuclear chromatin
typical of apoptosis. Note ease of identification of apoptotic cells (approx x 790). B. Ultrastructure. Transmission electron micrograph of apoptotic
neutrophil. Note intact plasma membrane, retention of granules, cytoplasmic vacuolation, and crescentic condensation of nuclear chromatin
(approx x 7900). C. The ladder pattern of internucleosomal DNA fragmentation in apoptotic neutrophils (right lane). One percent agarose gel
electrophoresis of DNA extracted from low molecular weight chromatin (resisting centrifugation at 25,000 g) of freshly isolated neutrophils (center
lane) and apoptotic neutrophils (right lane). Left lane shows size standards [ref. 11 for details]. Note lack of fragmentation in low molecular wt
DNA of freshly isolated cells. D. Recognition by glomerular inflammatory macrophages. Macrophages were isolated by enzymatic digestion of
glomeruli from kidneys of rats with nephrotoxic nephritis, attached to tissue culture wells and interacted with apoptotic neutrophils for 30 minutes.
Non-ingested neutrophils were washed away, and the monolayer fixed and stained for myeloperoxidase. The dark stained (orange-brown) globules
within most macrophages (example arrowed) represent ingested neutrophils; the techniques used do not stain macrophage nuclei [11]. This
appearance was not seen in macrophages incubated with freshly isolated neutrophils (inverted microscope, approx >< 316).
evidence suggests that this enzyme is dependent upon Ca2 and
Mg2 and inhibited by Zn2, but its full biochemical character-
ization has yet to be achieved [5]. A number of laboratories are
hoping to clone and sequence this enzyme in the near future.
There has been intense interest in the intracellular events
controlling apoptosis [6—9]. Cycloheximide and other inhibitors
of protein synthesis do not have consistent effects upon model
systems of programmed cell death; some are inhibited, others
enhanced, and sometimes there is no effect. These observations
have prompted Cohen et al [7] to propose that there may be (at
least) three classes of control mechanism which regulate initi-
ation of the final common pathway of endogenous endonuclease
activation. Cycloheximide inhibits apoptosis induced in thymo-
cytes by exposure to glucocorticoid, or low dose irradiation,
indicating that there may be induction mechanisms which
require new protein synthesis before apoptosis can proceed
(a marked distinction from necrosis). Such controls are likely to
play critical roles in deletion of T cell clones during the
development of immunological tolerance. Thus, antigen recep-
tor stimulation of lymphocytes of thymic lineage can induce
apoptosis by such cycloheximide-sensitive mechanisms.
Whether these pathways or those leading to proliferation are
chosen by the cell may depend upon the balance of signalling
pathways activated [8]. However, protein synthesis inhibitors
have no effect on the more rapid, but nevertheless typical,
morphological and biochemical changes of apoptosis which
occur in cells exposed to cytotoxic T lymphocytes or agents
such as gliotoxin, a fungal product. Thus there must be a class
of transduction mechanisms which bypass the "induction"
pathways and the associated requirement for gene expression.
Finally, cycloheximide can accelerate apoptosis in cells appar-
ently destined to die, such as neutrophils and other cells of
myeloid lineage, which undergo apoptosis spontaneously. A
number of investigators have postulated that this effect of
cycloheximide reflects interference with synthesis of short
half-life proteins which might normally keep either induction or
transduction mechanisms in check; therefore Cohen has sug-
gested the existence of a third class of release mechanisms
involved in governing apoptosis. For example, although the
mechanisms are not yet clear, both the bcl-2 oncogene and viral
genes can suppress apoptosis [9].
Depending on cell type, these intracellular tiers of control
may be subject to regulation by extracellular factors, just as
climatic stimuli can influence autumn leaf fall. Thus pro-
grammed cell death can be initiated by hormones such as
steroids or TNF, both may also follow withdrawal of growth
factors, as in mature T cells deprived of IL-2. Furthermore,
IL- 1, endotoxin and other agents can inhibit apoptosis in cells
undergoing the process spontaneously or following exposure to
inducing stimuli. These observations have fuelled interest in the
cell surface receptors, signalling pathways and newly expressed
genes involved in apoptosis. In therapeutic terms, these studies
hold the ultimate prospect of selective induction of apoptosis in
"undesirable" cells. For example, binding of a 52 kD surface
protein by the monoclonal antibody APO-l can induce pro-
grammed death in leukemic lymphocytes. However, this exam-
ple also illustrates problems of specificity inherent in attempted
therapeutic manipulation of a fundamental biological process;
the APO-l antigen is borne by a wide range of cell types [101.
Inflammatory leucocyte clearance by apoptosis
Recent studies indicate that inflammatory leucocytes undergo
apoptosis leading to uptake by phagocytes. It appears that this
is a mechanism for the safe disposal of leucocytes from inflamed
sites [11].
Our work has focused on the archetypal inflammatory leuco-
cyte, the neutrophil polymorphonuclear granulocyte. Sum-
moned from the blood by rapidly generated chemotatic factors,
it is the first cell to arrive at perturbed sites. The neutrophil has
evolved systems which generate reactive oxygen intermediates,
powerful degradative granule enzymes and toxic cationic pro-
teins. However, these weapons of defence against invading
micro-organisms can also inflict injury upon host tissues. In-
deed, there is growing evidence that neutrophils and their toxic
contents play a critical role in a number of inflammatory
diseases.
Clearly, the removal of neutrophils is a prerequisite for the
resolution of acute inflammation, Many have assumed that this
is invariably achieved by neutrophil necrosis and disintegration
in situ. However, this would inevitably expose tissues to toxic
neutrophil contents with risk of exacerbation of injury, and
could amplify leucocyte infiltration by the enzymatic generation
of chemotactic fragments from extracellular matrix proteins
such as fibronectin. An alternative disposal mechanism for
inflammatory neutrophils, which avoids uncontrolled release of
toxic contents, involves recognition and ingestion by macro-
phages of the senescent but intact granulocyte. This mode of
neutrophil removal was first described around 100 years ago by
Metchnikoff in his seminal studies of the resolution phase of
experimentally-induced inflammation in animals, and has since
been reported at inflamed sites on many occasions. Indeed, in
models such as the experimentally inflamed peritoneum, which
allow repeated sampling of the cellular infiltrate, phagocytosis
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of intact cells appears to be the dominant route of neutrophil
disposal.
In the last few years the mechanisms responsible for macro-
phage phagocytosis of senescent neutrophils have begun to be
elucidated. Newman, Henson and Henson [12] reported that
macrophages recognize and ingest intact neutrophils which
have been aged overnight in culture; freshly isolated neutro-
phils are not recognized. Subsequently, using improved meth-
ods of neutrophil isolation and culture (such that after 24 hours
in vitro > 98% of cells were viable by Trypan blue dye
exclusion) we in Haslett's group were able to show that aging
neutrophils spontaneously undergo typical morphological and
biochemical changes of apoptosis, and that such apoptotic
neutrophils are those recognized by macrophages [11]. In vitro,
phagocytosis of apoptotic cells is extremely rapid, occurring in
a few minutes, and once ingested, neutrophils are quickly
broken down. Consequently, even if there is a large flux of cells
undergoing apoptosis and recognition, neither free apoptotic
cells nor macrophages containing very recently ingested intact
neutrophils (when they can be identified as being apoptotic) will
be frequent in vivo. This point is well illustrated by studies of
tissue involution and resorption, where large areas of tissue
undergo programmed death but few phagocytes contain recog-
nizable apoptotic cells at any one time. Nevertheless, there is
histological evidence of neutrophil apoptosis leading to uptake
by macrophages in the inflamed human knee joint and respira-
tory tract, confirming the in vivo relevance of these processes.
We view these events as constituting a neutrophil disposal
mechanism which has potential to limit tissue injury. Thus,
from the point of view of the neutrophil, undergoing apoptosis
in vitro does not lead to spontaneous discharge of granule
contents, indicating that neutrophils can be cleared without
inevitable release of these histotoxic molecules. Furthermore,
macrophage ingestion of apoptotic neutrophils does not incite
secretion by the phagocyte of proinflammatory mediators such
as eicosanoids or granule enzymes [13]. Indeed, these in vitro
findings are entirely in accord with the general observation that
removal of cells by apoptosis does not incite inflammation.
The lack of responsiveness on the part of the macrophage
appears to be determined by the mechanism by which the
apoptotic cell is recognized rather than the particle itself—
opsonic receptor-mediated ingestion of apoptotic neutrophils
coated with a rabbit antiserum does induce mediator release.
The normal recognition of apoptotic neutrophils by monocyte-
derived macrophages is specifically inhibited by cationic amino
sugars and amino acids in a charge-dependent manner, which
suggests that anionic groups on the neutrophil surface are
important. These appear to be unaffected by broad-spectrum
proteases. On the macrophage, a critical role for the c/33
vitronectin receptor integrin was indicated by the inhibitory
effects of peptides and proteins bearing the Arg-Gly-Asp tripep-
tide adhesion signal and monoclonal antibodies to both subunits
of this integrin heterodimer [14]. Data presented in abstract
form, elsewhere in this symposium, suggest that macrophage-
secreted thrombospondin may be a component of a "molecular
bridge" between macrophage a.j33 and the apoptotic neutro-
phi!, but the cell surface structure determining recognition of
apoptotic neutrophils as "senescent-self" remains to be deter-
mined. There is evidence from studies of rodent thymocytes
induced to undergo apoptosis that either exposure of N-acetyl
glucosamine residues normally hidden in the mature glycan
chains of the cell surface [2], or exposed phosphatidylserine (V.
Fadok, P.M. Henson, personal communication), may underlie
recognition by macrophages. However, lack of effect of the
appropriate inhibitors suggests that different structures are
involved in our system. Consequently, different cell types may
employ different cell surface markers to signal their apoptotic
status to phagocytes.
The potential benefits of apoptosis leading to the removal of
senescent neutrophils before they disintegrate are self-evident.
The apoptotic program is also available to monocyte/macro-
phages. For example monocytes cultured in the absence of
serum or LPS spontaneously undergo programmed death, while
inflammatory monocyte-derived macrophages can be induced
to undergo apoptosis by agents such as gliotoxin. However, it is
not known whether monocyte/macrophages undergo such a fate
in vivo, or which factors might lead to this. Much work has
been done on programmed death in cells of the lymphoid
lineage, but is unclear whether antigen or other stimuli may lead
to apoptosis rather than proliferation of lymphocytes at an
inflamed site. However, some similarity with mechanisms re-
lating to neutrophils is to be expected, since human peripheral
blood lymphocytes induced to undergo apoptosis by irradiation
are recognized via macrophage af3.
Apoptosis of leucocytes in glomerular inflammation
In common with inflammation at other sites, neutrophils are
implicated in the pathogenesis of glomerulonephritis. These
cells can injure glomerular components in vitro, damage iso-
lated perfused kidneys, and injure glomeruli in vivo, as shown
by the effects of specific depletion and reconstitution of circu-
lating neutrophils upon the initial self-limited phase of nephritis
induced by heterologous nephrotoxic globulin. Neutrophils
may also play an important role in the intitiation of the later
inonocyte-dependent autologous phase (caused by develop-
ment of antibodies to heterologous antibody fixed to basement
membrane), where persistent inflammation progresses to scar-
ring. Neutrophil infiltration of the glomeruli is much less
striking than in the heterologous phase, but nevertheless,
specific neutrophil depletion just prior to the onset of the
autologous phase abrogates tissue injury. Moreover, in a model
of lung inflammation monocyte influx was shown to depend
upon initial neutrophil accumulation. Therefore, despite an
apparent lack of neutrophil infiltration in certain types of human
glomerulonephritis, this does not preclude a pathogenetic role
for the cell at an earlier stage of the disease. Furthermore,
neutrophils are prominent in the glomeruli of patients with
acute renal injury associated with a wide spectrum of diseases
ranging from systemic vasculitis to IgA nephropathy. Conse-
quently, safe disposal of neutrophils is likely to be an important
event promoting resolution of glomerulonephritis.
There is now evidence that neutrophil apoptosis leading to
clearance by macrophages occurs in inflamed glomeruli. It
should be appreciated that identification of apoptotic cells
within glomeruli is not easy, given the likely speed of removal
of these cells, the difficulties of picking them out within a
densely cellular tissue, and the fact that at the light microscop-
ical level it may be hard to differentiate the cell type undergoing
apoptosis. Despite these difficulties, Harrison reported apop-
totic cells in the glomeruli of patients with various forms of
Savill: Apoptosis in glomerulonephritis 611
nephritis, most frequently in those infiltrated by neutrophils
[15]. With hindsight many of these cells appear to be apoptotic
neutrophils, but their paucity precluded identification by elec-
tron microscopy, since the very thin tissue slices employed
necessarily sample only a small volume of tissue, Recently, we
have observed that inflammatory macrophages isolated from
the glomeruli of rats with nephrotoxic nephritis contain apop-
totic neutrophils in various stages of degradation, indicating
that these had been ingested in vivo. Furthermore, glomerular
macrophages preferentially recognize apoptotic neutrophils ex
vivo (Fig. 1D). Taken together with Harrison's findings these
data indicate that neutrophil apoptosis leading to uptake by
inflammatory macrophages can occur in glomeruli, as at other
inflamed sites [16].
However, cells other than the macrophage can ingest apop-
totic cells. For over 20 years it has been known that the
glomerular mesangial cell can clear particulate debris reaching
the glomerulus. Attracted by the concept of the mesangial cell
as a "glomerular dustbin", we have recently shown that
cultured human mesangial cells can also ingest neutrophils
undergoing apoptosis [16]. Furthermore, there is evidence that
this occurs in vivo. In rats with nephrotoxic nephritis we have
been able to detect neutrophil debris within mesangial cells
immunopurified on the basis of Thy 1 expression [16]. Finally,
albeit in a single case of acute glomerular injury, Arends and
Harrison have obtained electron micrographs showing apop-
totic cells within mesangial cells [171.
Our current hypothesis is that in glomerulonephritis, both
inflammatory macrophages (derived from blood monocytes)
and intrinsic mesangial cells mediate clearance of infiltrating
leucocytes undergoing apoptosis. The quantitative contribution
of each type of phagocyte, and the mechanisms and conse-
quences of uptake of apoptotic neutrophils are under study.
Apoptosis of intrinsic glomerular cells
Abnormal proliferation of intrinsic glomerular cells, particu-
larly mesangial cells, is a common consequence of glomerular
inflammation. This may be a pathway leading to abnormal
deposition of extracellular matrix and sclerosis or scarring of
the glomerulus. However, a glomerulus can recover from
abnormal proliferation of intrinsic cells. This is well illustrated
by clinical examples such as post-streptococcal glomerulone-
phritis, or animal models such as the self-limited mesangial
proliferation in the rat which follows mesangiolysis induced by
antiserum to Thy 1 antigen.
Harrison suggested that apoptosis of unwanted intrinsic
glomerular cells might allow a hyperplastic glomerulus to return
to normal [15]. At present this attractive postulate remains
highly speculative. However, this possibility draws support
from evidence, detained above, that programmed cell death can
occur in the diseased glomerulus, and that glomerular cells can
take up apoptotic cells. Furthermore, it is clear that apoptosis is
a remodelling mechanism available to the kidney: a wave of
apoptosis in tubular epithelial cells is observed during recovery
from lead nitrate-induced renal hyperplasia. Indeed, there is
evidence which suggests that proliferating mesangial cells can
undergo apoptosis. Firstly, both mesangial cells in injured
glomeruli and fibroblasts in injured skin acquire myofibroblast
characteristics such as s-smooth muscle actin. Elegant studies
by Gabbiani's group show that during resolution and remodel-
ling of the inflammatory response induced by a skin wound
there is a wave of deletion of myofibroblasts by apoptosis. This
implies that stimulated myofibroblast-like mesangial cells might
also be capable of undergoing apoptosis. Secondly, preliminary
data from our laboratory and others indicates that cultured
mesangial cells displaying myofibroblast phenotypic features
can indeed undergo apoptosis. At present, it is not known if
other glomerular cells are "turned over" by apoptosis, but
there are indications that they have the program available; for
example, TNF can induce apoptosis in vascular endothelial
cells.
Finally, there are hints that alterations in the program of
apoptosis may promote scarring in the kidney. For example,
Muller and colleagues have shown that fibroblasts from human
kidneys with interstitial fibrosis not only undergo more rapid
growth and division in culture than cells from normal kidneys,
but having entered the post-mitotic phase, they also take up to
20 weeks longer before they finally undergo apoptosis. There-
fore, delay of apoptosis (by unknown factors) represents a
mechanism by which "unwanted" cells could accumulate in the
diseased kidney, just as the bcl-2 oncogene can contribute to
oncogenesis by promoting tumor cell longevity.
Conclusions and future prospects
The concepts and preliminary data presented here indicate
that apoptosis is likely to play an important role in the inflamed
glomerulus. In particular, it appears that programmed death
may have beneficial effects, by promoting removal of infiltrating
leucocytes and, perhaps, "unwanted" intrinsic cells. Since
apoptosis can be regulated by external stimuli there is the
(distant) prospect that this process might be regulated for
therapeutic effect. It would be essential to be able selectively to
delete a particular cell type, to know which cells to eliminate at
any particular stage of nephritis, to understand how to persuade
just the right number of cells to undergo suicide, and above all
to do minimum harm to the patient! A more realistic prospect is
that work on apoptosis in the glomerulus may provide new
experimental approaches to unravelling the pathogenesis of
persistent inflammation and scarring. Thus it may be possible to
define factors which lead to death of neutrophils by disintegra-
tion and release of toxic contents likely to promote persistence
of inflammation. This might occur either because of failure of
phagocyte uptake of apoptotic cells, or by interruption of the
death program such that senescent neutrophils undergo necro-
sis. Manipulation of such factors might prove to be of thera-
peutic benefit.
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